Ignite Creation Date:
2024-05-05 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00311480
Status:
COMPLETED
Last Update Posted:
2007-03-13
First Post:
2006-04-04
Brief Title:
Safety and Immunogenicity of Two Doses Administered Three Weeks Apart of TwoSurface Antigen Adjuvanted With MF59C1 Influenza Vaccines in Non-Elderly Adult and Elderly Subjects
Sponsor:
Novartis
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2006-04-04
First Submit QC Date:
April 4 2006
Study First Post Date:
2006-04-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-03-12
Last Update Post Date:
2007-03-13
Last Update Post Date Type:
ESTIMATED